METHODS
This is a descriptive cross-sectional study. Fifty-four patients with
HCC who either visited the OPD or were admitted to the TUTH under the
Department of Gastroenterology from March 2020 to August 2022 were
considered for the study. These patients had at least one clinical,
radiological, or biochemical evidence of HCC. We analyzed the risk
factors, clinical characteristics, and treatment modalities in patients
with HCC. The diagnosis of HCC was made by detailed clinical
examination, imaging modality (dynamic CT scan or MRI of the abdomen)
which show early arterial enhancement and venous washout of the lesion,
or with the biopsy of the lesion whenever necessary. Predetermined
proforma was used as a tool for data collection. The study was approved
by the Institutional Review Committee of the Institute of Medicine
(reference number: 132/ (6-11) E2/076/077).